Aditi Bhargava·Dec 7, 2023Missed Opportunities of Making a Real IMPACT By Early COVID-19 StudiesIn the early days of the COVID-19 pandemic, intensive care unit (ICU) admissions associated with COVID-19 illness were recognized as…
Sylvia Makinia·Jun 8, 2021Fact-check: Remdesivir is Not a COVID-19 VaccineThe claim that Remdesivir is a coronavirus vaccine produced to be tested in African countries is false.
Akshit Chawla·Apr 16, 2021Why licensing hurdles are causing Remdesivir shortageEven during this crisis, not every manufacturer is allowed to manufacture remdesivir, other life-saving drugs and vaccines of covid19
Grupo de Investigación en Inmunología y Virología·Jan 7, 2021Reposicionamiento de fármacos frente a COVID-19: la esperanza en remdesivir y favipiravirEl reposicionamiento de fármacos en ensayos clínicos, puede representar una estrategia atractiva porque facilita el descubrimiento de…
Geneva Health Files·Jan 7, 2021The Need for Regulatory Coherence: Lessons from RemdesivirOriginally published December 3rd, 2020 on Geneva Health Files
